+499.5%
MRNA vs RJF
+7.8%
+491.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RJF | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.6% | -0.7% | -1.7% |
| 7D | +5.5% | -0.6% | +6.1% | +5.6% |
| 30D | +158.7% | -1.3% | +160.0% | +160.3% |
| 3M | +182.1% | +18.9% | +163.2% | +155.1% |
| 6M | +151.8% | +15.0% | +136.8% | +130.5% |
| YTD | +393.6% | +12.2% | +381.3% | +343.3% |
| 1Y | +499.5% | +5.6% | +493.8% | +433.9% |
| All | +499.5% | +7.8% | +491.6% | +433.9% |
Cumulative growth
Daily Returns
Daily percentage return beside RJF.
Daily Out/Under-Performance
Portfolio return minus RJF return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RJF return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RJF wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling